Evidence map›Paper›PMID 35111493›Full record

ArticleFujita medical journal2019

Distal gastrectomy for gastric carcinoma in patients with diabetes mellitus: impact of reconstruction type on glucose tolerance.

Kenichi Nakamura, Koichi Suda, Atsushi Suzuki, Masaya Nakauchi, Susumu Shibasaki, Kenji Kikuchi, Tetsuya Nakamura, Shinichi Kadoya, Kazuki Inaba, Ichiro Uyama

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Fujita medical journal, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 95% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Kenichi NakamuraDivision of Upper GI, Department of Surgery, School of Medicine, Fujita Health University, Toyoake, Aichi, Japan.
Koichi SudaDivision of Upper GI, Department of Surgery, School of Medicine, Fujita Health University, Toyoake, Aichi, Japan.
Atsushi SuzukiDepartment of Endocrinology and Metabolism, School of Medicine, Fujita Health University, Toyoake, Aichi, Japan.
Masaya NakauchiDivision of Upper GI, Department of Surgery, School of Medicine, Fujita Health University, Toyoake, Aichi, Japan.
Susumu ShibasakiDivision of Upper GI, Department of Surgery, School of Medicine, Fujita Health University, Toyoake, Aichi, Japan.
Kenji KikuchiDivision of Upper GI, Department of Surgery, School of Medicine, Fujita Health University, Toyoake, Aichi, Japan.
Tetsuya NakamuraDivision of Upper GI, Department of Surgery, School of Medicine, Fujita Health University, Toyoake, Aichi, Japan.
Shinichi KadoyaDivision of Upper GI, Department of Surgery, School of Medicine, Fujita Health University, Toyoake, Aichi, Japan.
Kazuki InabaDivision of Upper GI, Department of Surgery, School of Medicine, Fujita Health University, Toyoake, Aichi, Japan.
Ichiro UyamaDivision of Upper GI, Department of Surgery, School of Medicine, Fujita Health University, Toyoake, Aichi, Japan.
Fujita Health University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesCurrent evidence regarding metabolic surgery suggests that different types of digestive tract reconstruction can result in differences in postoperative glucose tolerance. This study evaluated the impact of Billroth I (B-I), Billroth II (B-II), and Roux-en-Y (R-Y) procedures on peri-operative glucose tolerance in patients with gastric carcinoma who had diabetes mellitus.

methodsA single-institution, retrospective cohort study was conducted using data from patients who underwent totally laparoscopic distal gastrectomy. These patients were grouped according to the type of reconstruction (B-I, B-II, or R-Y). After the operation, we addressed the changes in glucose tolerance-including changes in HbA1c levels, remission of diabetes, and overall effects of the treatment.

resultsWe studied 57 patients (B-I, n=32; B-II, n=17; R-Y, n=8). B-II and R-Y reconstruction improved HbA1c levels more than B-I. Notably, R-Y improved tolerance the most (B-I vs. B-II,

conclusionsEither R-Y or B-II should be considered the primary option for patients with gastric carcinoma and diabetes when glycemic control is insufficient.

Indexed as

Diabetes mellitusReconstructive surgical proceduresStomach neoplasms

Identifiers

PMID35111493
PMCPMC8766235
OpenAlexW2930775273

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.